Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Mge Energy Mgee Stock A Growth Play Price At 80.90 Down 0.25 20260410 Enlt Stock Analysis Enlight Renewable Energy Ltd 1.55 Dip 69.87 Price Outlook 20260403 Is Umb Umbfo Stock Overpriced Now Price At 25.95 Down 0.02 20260406 Is Waste Wcn Stock Good For Portfolio Price At 165.85 Down 0.14 20260406 Is Terex Corporation Tex Stock Ready To Move Price At 58.33 Down 0.32 20260406 The MA impact hidden in First FFBC earnings Q1 2026 EPS Exceeds Expectations ProCap PCAPU Stock Valuation Analysis 029 20260418 STRW Strawberry Fields REIT Inc delivers Q4 2025 earnings beats and 324 percent year over year revenue growth yet shares dip 263 percent SLDE Slide Insurance Holdings Inc posts 373 percent EPS surprise in Q4 2025 shares rise 337 percent on upbeat investor sentiment How Impact BioMedical IBO translates market opportunities into growth 095 20260511 Communication Services Select Sector SPDR Fund XLC AI Trade Resurgence Signals Sustained Bullish Leadership for Growth Equities How Liberty FWONK is navigating logistics challenges Q4 2025 Earnings Fall Short Market Recap Tech outperforms peers as broad markets edge lower Malibu Boats MBUU Stock Trend Continuation Trend Strengthens 20260420 Is Figma FIG stock fairly valued Figma delivers 208 percent EPS beat topping analyst expectations Deere Company DE PreEarnings Analysis Ahead of Q2 2026 Results MDCX Medicus Pharma reports far wider Q4 2025 loss than estimates even as shares tick higher today Xcel Energy Inc XEL Q1 2026 Earnings Mixed TopLine Results InLine EPS Amid Sector Rotation Headwinds How Dollar Gen DG balances growth with profitability Bullish Momentum 20260505 Bill Ackman Takes Stake in Microsoft Echoing Jim Cramers Views on Competitive Flexibility Latin Lawyer MA Roundtable Sheds Light on Shifting Deal Dynamics in the Region Nebius NBIS Down 055 How Low Could It Go 20260515 Backblaze BLZE Reports Mixed Q1 2026 Revenue Beats but EPS Misses ReNew RNW Stock Analysis Falls 219 Watching 508 20260519 Ukraine Attacks Escalate Geopolitical Risk Global Markets Weigh SafeHaven Shifts NexGel Inc NXGLW Stock Consolidating at 005 Next Move Ahead 20260514 Standard Chartered to Eliminate Nearly 8000 Jobs as AI Transformation Accelerates ICON plc ICLR Q3 2025 Earnings Soft Quarter Raises Questions Yardeni Warns of Potential July Rate Hike as Bond Vigilantes Target Incoming Fed Chair Warsh Samsung Faces Potential Strike as Union Demands Overhaul of Bonus System NCTY Q1 2012 Earnings Narrower Loss Beats Estimates Stock Edges Higher Indias Strategic Pivot Modis Europe Trip Secures Tech and Defense Deals to Diversify Away from China and US Dependence UK Chancellor Reeves Announces VAT Cut for Theme Parks and Childrens Meals to Ease CostofLiving Pressures Vincent Bollors Media Influence Sparks Debate Over Democracy and EU Regulatory Response Jim Cramer Suggests Potential Entry Point for VF Corporation Investors Data Centre Expansion in Chile Exacerbates Water Scarcity Threatening Tech Hub Ambitions TAOX Q4 2024 Earnings EPS Misses Estimates Amid Operational Challenges Codere Online Q4 2025 Earnings Narrow Loss Surprises on the Downside Stock Edges Up Eversource Energy ES Q1 2026 Earnings EPS Falls Short by 24 Amidst Utility Cost Pressures ADTX Q3 2025 Earnings Significant Loss per Share Amidst No Revenue Reported Stock Plunges NTZ Q4 2011 Earnings Significant EPS Miss as Company Reports WiderthanExpected Loss Eva Live Inc GOAI Faces Pressure as Shares Slip Toward Key Support GSK GSK Holds Steady With Modest Gains as Pharma Sector Navigates Uncertainty Sally Beauty Holdings SBH Posts Modest Gain Testing Key Resistance Zone Is USA TODAY TDAY stock testing support Weakens 20260420 Is MFS MFM stock reflecting its growth potential PXED Phoenix smashes Q1 estimates with 65 EPS beat but shares dip despite strong results as investors eye risks Aspire Bio ASBPW Stock Mispriced Surges 20260420 Is Agnico Eagle AEM stock testing breakout levels Q4 2025 Below Expectations MAIA Biotechnology MAIA delivers Q4 earnings beat cutting losses by 32 as clinical pipeline advances